Mirae Asset Global Etfs Holdings Ltd. Abbott Laboratories Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 152,720 shares of ABT stock, worth $19.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
152,720
Previous 165,997
8.0%
Holding current value
$19.9 Million
Previous $22.6 Million
9.4%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,654Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...